Strand, Vibeke

Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0

Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.-A., Conaghan, P. G., Bingham, C. O., Brooks, P., Landewé, R., et al. (2014) · Journal of Clinical Epidemiology

Delphi Technique in ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 781

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

Aletaha, D., Landewe, R., Karonitsch, T., Bathon, J., Boers, M., Bombardier, C., Bombardieri, S., Choi, H., Combe, B., Dougados, M., et al. (2008) · Arthritis Care & Research

Rheumatoid Arthritis Research and TherapiesStatistical Methods in Clinical Trials

Cited by 214

Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations

Taylor, A. M., Phillips, K., Patel, K. V., Turk, D. C., Dworkin, R. H., Beaton, D., Clauw, D. J., Gignac, M. A. M., Markman, J. D., Williams, D. A., et al. (2016) · Pain

Musculoskeletal pain and rehabilitationPain Management and Opioid Use

Cited by 208

Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations

Smith, S. M., Dworkin, R. H., Turk, D. C., McDermott, M. P., Eccleston, C., Farrar, J. T., Rowbotham, M. C., Bhagwagar, Z., Burke, L. B., Cowan, P., et al. (2020) · Pain

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 194

An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial

Pincus, T., Strand, V., Koch, G., Amara, I., Crawford, B., Wolfe, F., Cohen, S., & Felson, D. (2003) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesStatistical Methods in Clinical Trials

Cited by 146

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology

Beaton, D. E., Maxwell, L. J., Shea, B. J., Wells, G. A., Boers, M., Grosskleg, S., Bingham, C. O., Conaghan, P. G., D’Agostino, M. A., de Wit, M. P., et al. (2019) · The Journal of Rheumatology

Delphi Technique in ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 96

Use of “spydergrams” to present and interpret SF-36 health-related quality of life data across rheumatic diseases

Strand, V, Crawford, B., Singh, J., Choy, E., Smolen, J. S., & Khanna, D. (2009) · Annals of the Rheumatic Diseases

Health Systems, Economic Evaluations, Quality of LifeMusculoskeletal pain and rehabilitation

Cited by 88